COMP <GO>
CHDN vs PG // 10Y YIELD & FRED MACRO BETA
Churchill Downs Incorporated (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: CHDN 6
— PG 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: CHDN
LAST: $94.83 (+4.03%) • MKT CAP: $6.25B
macro-sensitivity
0.93
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHDN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHDN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 25.40% | -16.20 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.0x | 16.2x | -2.20 | CHDN | /valuation <GO> |
| Free Cash Flow Yield | 4.88% | 3.77% | +1.11 | CHDN | /fcf-yield <GO> |
| Operating Margin | 23.40% | 24.30% | -0.90 | PG | /operating-margins <GO> |
| Net Profit Margin | 13.10% | 19.00% | -5.90 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 0.30% | +6.70 | CHDN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.49% | 2.65% | -2.16 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.42 | 5.59 | -4.17 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.50% | +0.20 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 73.2 | 62.7 | +10.51 | CHDN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.93 | 0.87 | +0.06 | CHDN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.2x | 21.7x | -6.50 | CHDN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.25B | $372.21B | -$365.96B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHDN REV | PG REV | CHDN GROSS % | PG GROSS % | CHDN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.93B | $84.28B | 44.0% | 51.2% | $297.3M | $14.04B |
| FY 2024 | $2.73B | $84.04B | 44.0% | 51.4% | $355.0M | $16.52B |
| FY 2023 | $2.46B | $82.01B | 44.0% | 44.0% | $356.6M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHDN // BETA 0.93
PG // BETA 0.87